S. Gagné

Transconjunctival XEN45 Implantation for Glaucoma Performed at the Slit Lamp: A Pilot Study

Shawn L Cohen, D. Yuen, S. Gagné, 2022, Journal of glaucoma.

Refractive outcomes in nanophthalmic eyes after phacoemulsification and implantation of a high‐refractive‐power foldable intraocular lens

I. Ahmed, K. Baig, Harmanjit Singh, 2015, Journal of cataract and refractive surgery.

Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.

M. Harissi-Dagher, Y. Agoumi, K. Moussally, 2012, American journal of ophthalmology.

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

M. Coote, R. Lewis, T. Aung, 2019, Drugs.

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Dawn Y. Lim, John C. Greiner, H. Thieme, 2021, Drugs.

Outcome of viscodilation and tensioning of Schlemm's canal for uveitic glaucoma.

Karim Hammamji, P. Harasymowycz, E. Kalin-Hajdu, 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection

J. Myers, I. Ahmed, Vanessa Vera, 2020, Clinical ophthalmology.

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.

M. Coote, R. Lewis, S. Mansberger, 2017, American journal of ophthalmology.

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial.

M. Coote, S. Mansberger, A. Crichton, 2017, American journal of ophthalmology.